Quarterly sales of arthroscopic devices reached $81 million, up from $70.6 million from the same quarter last year. Over the six-month period ending June 30, the company saw similar growth, from $146 million in 2011 to $167.2 million in 2012. This increase indicates a 14.5 percent increase.
More Articles on Orthopedic Devices:
CareFusion Reports $968M 4Q Revenue, Up 3%
8 Spine Device Company 2Q Financial Reports
Mazor Robotics Enters Into Agreement With Investors to Receive $15M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
